Pharmacogenetics
Therapeutics
– branch of pharmacology that deals with clinical applications
fundamental therapeutic questions: what drug?; what dose?; what formulation?; how long?
drug administration requires:
dose-response relationship
determined clinical endpoint -
exactly
what effect are we trying to achieve? (qualitative and quantitative)
monitoring of efficacy and toxicity
a dose that is effective but not toxic (the correct dose is: enough)
pharmacologic effects are only modifications of intrinsic physiology - we modify responses, we don’t create them
therapeutic effects are a function of the pharmacodynamics and pharmacokinetics
therapeutics is complicated because these parameters are not constant between individuals
dynamics and kinetics can be altered by disease states, age, pregnancy, genetic determinants, etc.
we test drugs on healthy humans and animals
Þ
how useful is this information?
Effect of Disease State on Drug Response
Absorption
affected by:
altered gastric emptying
decreased GI blood flow
ileus (gastric obstruction)
exongenous buffers
i.e. absorption of aspirin is impaired during a migraine attack
Þ
aspirin isn’t therapeutic for migraines
diarrhea, thyroid dysfunction, CHF, CF, and many other diseases affect absorption
Distribution
affected by:
hemodynamic instability
inflammation
altered protein levels
synthesis of acute phase reactions
extravascular fluid collections
drug-drug interactions
disease states that affect distribution
decreased plasma protein: affects total drug concentration but not free drug concentration
nephrotic syndrome; malnutrition, short bowel syndrome; celiac disease; liver failure
decreased protein affinity or displacement
uremia; hyperbilirubinemia; drug-drug interactions; genetic alterations in albumin
increased tissue water: changes volume of distribution
congestive heart failure; renal failure; liver failure with ascites
Metabolism
affected by:
hemodynamic instability (altered delivery to liver and kidneys)
hypoxemia: oxygen may become limiting in some reactions
drug-drug interactions
hormone or autocoid use as pharmacologic rather than physiologic agents
i.e. viral illness (especially influenza) can decrease drug metabolism via the release of cytokines
disease states that affect metabolism
viral infections
inborn errors of metabolism
congestive heart failure
bacterial sepsis
cystic fibrosis
malnutrition
chemical intoxicants
Excretion
affected by:
altered vascular volume
altered renal blood flow
hypoxemia
nephrotoxic agents
Pharmacodynamics
affected by: altered receptor affinity or number; up or down regulation of receptors
Pharmacogenetics
mostly relates to altered drug metabolism
genetic differences can be further modified by other factors (see above)
may lead to alterations in intensity or duration of drug effect; or uncommon/abnormal effects
types of pharmacogenetic disorders
decreased or defective proteins
succinylcholine apnea; acetylation polymorphism; inc susceptibility to drug induced hemolysis
P450 polymorphisms (i.e. altered ratios of isoforms
Þ
altered metabolism; prolonged or exaggerated or altered drug effect; drug-drug interations
increased drug resistance
induction
Þ
altered drug response
abnormal drug distribution